NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Revolution Biomanufacturing Inc.

Revolution Biomanufacturing Inc.

Private
Worcester, MassachusettsFrontier & Industrial Techhttps://www.revolutionbiomanufacturing.com/

Last Round

Accelerator

Dec 12, 2025

Company Overview

Revolution Biomanufacturing Inc. is a biotechnology company that provides end-to-end biomanufacturing solutions, including mRNA synthesis, regulatory strategy, and process development, to accelerate the development of personalized medicine and other therapies.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Pharma Supply Chain, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

cell-free synthesisCDMObiomanufacturingenzymatic synthesisspecialty ingredientscontract development and manufacturing organizationcell-free manufacturingsynbiobiocatalysissustainable ingredientspharmaceutical intermediatesflavor compoundsfragrance compoundsbioactive ingredientssequence optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Revolution Biomanufacturing Inc. Comps

Public and private peers based on sector, stage, and business model.

Revolution Biomanufacturing Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Revolution Biomanufacturing Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 12, 2025

Key People

Founding team and executive leadership

Molly McGlaughlin

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2024

    Grew 36% QoQ, from 11 to 15 employees.

  • Jan 23, 2024

    Grew 225% QoQ from 4 to 13 employees.

Revolution Biomanufacturing Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Revolution Biomanufacturing Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Revolution Biomanufacturing Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWorcester, Massachusetts
Employee Range7
Year Founded2025
Last FundingDec 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.